A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients with C3-Glomerulopathy

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517992-19-00

Acronym

CPV-104-101

Enrollment

Registered

2025-06-02

Start date

2025-06-11

Completion date

Unknown

Last updated

2025-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C3 glomerulopathy (C3G)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria, Belgium, Czechia, France, Greece, Latvia, Lithuania, Netherlands, Portugal, Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026